Schedule 13G ownership disclosure

Tyra Biosciences Inc

COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 90240B106

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Canaan XI L.P.

    Shares: 2,930,444 · Class: 5.5%

  • Canaan Partners XI LLC

    Shares: 2,930,444.00 · Class: 5.5%

  • Canaan 2020+ Co-Investment L.P. - Series 7

    Shares: 443,885.00 · Class: 0.8%

  • Canaan Partners 2020+ Co-Investment LLC

    Shares: 443,885.00 · Class: 0.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-051409
Form type
SCHEDULE 13G/A
Filer
Canaan XI L.P.
CIK
CIK 1712417
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub